 |
|
Mailman School of Public Health researchers develop diagnostic test for pathogens
March 20, 2006Rapid identification of pathogens responsible for disease outbreaks critical for containment and implementation of public health measures
March 13, 2006-Researchers at the Greene Infectious Disease Laboratory at Columbia University's Mailman School of Public Health led by Thomas Briese, PhD, associate professor of Epidemiology, have developed a rapid, comprehensive diagnostic test for viral hemorrhagic fevers caused by the Ebola and Marburg viruses, as well as others. The new diagnostic tool is addressed in a paper published in the April 2006 issue of the Centers for Disease Control and Prevention's (CDC) Emerging Infectious Diseases. (The paper can be found online at www.cdc.gov/ncidod/eid/vol12no04/05-1515.htm)
Increasing international travel, trafficking in wildlife, political instability, and terrorism have made emerging infectious diseases a global concern. Viral hemorrhagic fevers (VHF) are of specific concern because they are associated with high morbidity and mortality (up to 80% mortality rates), and the potential for rapid dissemination through human-to-human transmission. The term "viral hemorrhagic fever" characterizes a severe multisystem syndrome associated with fever, shock, and bleeding caused by infection with one of a number of viruses, such as Ebola or Marburg.
"Currently, there is no way to treat most of these outbreaks," stated W. Ian Lipkin, MD, director of the Jerome L. and Dawn Greene Infectious Disease Laboratory at the Mailman School, and professor of Epidemiology, Neurology and Pathology at Columbia University. He added, "The most important first step is diagnostic-rapid identification of the exact pathogen responsible for an outbreak of disease is critical for containment and the implementation of public health measures, especially in instances where the agents are encountered out of their natural geographic context."
While other tools exist for the detection of VHF agents, none offers the sensitivity and speed of this new diagnostic screen, which incorporates MassTag PCR technology-providing the ability to simultaneously consider multiple agents, thereby reducing the time needed for differential diagnosis. To address the need for highly sensitive diagnostics, researchers built on an established method known as polymerase chain reaction that allows amplification of genetic sequences and on a technology previously used for DNA sequencing and detection of genetic polymorphisms. Genetic probes for pathogens were coupled to markers known as mass codes. After amplification, incorporated mass codes were detected by mass spectroscopy allowing identification of the pathogen.
To facilitate rapid differential diagnosis of VHF agents, Briese and colleagues established the "Greene MassTag Panel VHF v1.0," which can screen simultaneously for Ebola Zaire, Ebola Sudan, Marburg, Lassa virus, Rift Valley fever, Crimean-Congo hemorrhagic fever, Hantaan, Seoul, yellow fever, and Kyasanur Forest disease viruses.
These results confirm earlier work in respiratory diseases indicating that MassTag PCR offers a rapid, sensitive, specific, and economic approach to differential diagnosis of infectious diseases. Small, low-cost, or mobile APCI-MS units extend the applicability of this technique beyond selected reference laboratories.
Stated Dr. Lipkin, "This work represents an unprecedented collaboration in the creation of diagnostics for the developing world. The contributors to this work represent laboratories devoted to strengthening global disease surveillance and outbreak response capabilities." A vital part of the commitment includes validation of innovative, new detection tools for diagnosis of emerging and high-risk pathogens, as well as distribution of assays and reagents in global laboratory networks. The working group consisted of representatives from the following institutions:
- Jerome L. and Dawn Greene Infectious Disease Laboratory, Mailman School of Public Health, Columbia University, New York, USA
- Special Pathogens Unit, National Institute for Communicable Diseases, Sandringham, South Africa
- Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada
- United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, USA
- Bernhard-Nocht-Institute of Tropical Medicine, Hamburg, Germany
- Special Pathogens Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, USA
- Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada
- NIH, NIAID, USA
Columbia University's Mailman School of Public Health
"Currently, there is no way to treat most of these outbreaks," stated W. Ian Lipkin, MD, director of the Jerome L. and Dawn Greene Infectious Disease Laboratory at the Mailman School, and professor of Epidemiology, Neurology and Pathology at Columbia University. He added, "The most important first step is diagnostic-rapid identification of the exact pathogen responsible for an outbreak of disease is critical for containment and the implementation of public health measures, especially in instances where the agents are encountered out of their natural geographic context."
While other tools exist for the detection of VHF agents, none offers the sensitivity and speed of this new diagnostic screen, which incorporates MassTag PCR technology-providing the ability to simultaneously consider multiple agents, thereby reducing the time needed for differential diagnosis. To address the need for highly sensitive diagnostics, researchers built on an established method known as polymerase chain reaction that allows amplification of genetic sequences and on a technology previously used for DNA sequencing and detection of genetic polymorphisms. Genetic probes for pathogens were coupled to markers known as mass codes. After amplification, incorporated mass codes were detected by mass spectroscopy allowing identification of the pathogen.
To facilitate rapid differential diagnosis of VHF agents, Briese and colleagues established the "Greene MassTag Panel VHF v1.0," which can screen simultaneously for Ebola Zaire, Ebola Sudan, Marburg, Lassa virus, Rift Valley fever, Crimean-Congo hemorrhagic fever, Hantaan, Seoul, yellow fever, and Kyasanur Forest disease viruses.
These results confirm earlier work in respiratory diseases indicating that MassTag PCR offers a rapid, sensitive, specific, and economic approach to differential diagnosis of infectious diseases. Small, low-cost, or mobile APCI-MS units extend the applicability of this technique beyond selected reference laboratories.
Stated Dr. Lipkin, "This work represents an unprecedented collaboration in the creation of diagnostics for the developing world. The contributors to this work represent laboratories devoted to strengthening global disease surveillance and outbreak response capabilities." A vital part of the commitment includes validation of innovative, new detection tools for diagnosis of emerging and high-risk pathogens, as well as distribution of assays and reagents in global laboratory networks. The working group consisted of representatives from the following institutions:
- Jerome L. and Dawn Greene Infectious Disease Laboratory, Mailman School of Public Health, Columbia University, New York, USA
- Special Pathogens Unit, National Institute for Communicable Diseases, Sandringham, South Africa
- Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada
- United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, USA
- Bernhard-Nocht-Institute of Tropical Medicine, Hamburg, Germany
- Special Pathogens Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, USA
- Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada
- NIH, NIAID, USA
Columbia University's Mailman School of Public Health
Infectious Disease Current Events and Infectious Disease News RSSParents of new babies should be considered for a whooping cough booster, say experts
A booster vaccination for parents of new babies and other household members may be the most effective way of preventing the fatal form of whooping cough in young infants, say a group of paediatric intensive care doctors on bmj.com today.
Estrogen therapy could be dangerous for women with existing heart risk
Hormone therapy could accentuate certain pre-existing heart disease risk factors and a heart health evaluation should become the norm when considering estrogen replacement, new research suggests.
Study of ancient and modern plagues finds common features
In 430 B.C., a new and deadly disease-its cause remains a mystery-swept into Athens. The walled Greek city-state was teeming with citizens, soldiers and refugees of the war then raging between Athens and Sparta.
Global warming link to amphibian declines in doubt
Evidence that global warming is causing the worldwide declines of amphibians may not be as conclusive as previously thought, according to biologists. The findings, which contradict two widely held views, could help reveal what is killing the frogs and toads and aid in their conservation.
Purdue researcher invents molecule that stops SARS
A Purdue University researcher has created a compound that prevents replication of the virus that causes SARS and could lead to a treatment for the disease.
Penn Scientists Show How Body Determines Optimal Amount of Germ-Fighting B Cells
Researchers at the University of Pennsylvania School of Medicine can now explain how the body determines whether there are enough mature B-cells in the blood stream at any one time. These are the cells that produce antibodies against germs to fight infections.
Tibotec presents interim findings for TMC435, an investigational genotype 1 hepatitis C treatment
New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection.
New molecules with many branches will help unleash potential of nanotechnology
Materials science and the pharmaceutical industry could soon be revolutionized by emerging nanotechnologies based on designer molecules with long complex tree-and branch structures.
Rapid HIV testing in the ER boosts diagnoses, screening
One in every 50 people screened for a suspected sexually transmitted infection (STI) in the Emergency Department at Henry Ford Hospital was found to be infected with HIV using a rapid blood sample screening test.
Vaccinating family members offers important flu protection to newborns
Vaccinating new mothers and other family members against influenza before their newborns leave the hospital creates a "cocooning effect" that may shelter unprotected children from the flu, a virus that can be life-threatening to infants, according to researchers at Duke Children's Hospital.
More Infectious Disease Current Events and Infectious Disease News Articles
 | Infectious Disease Epidemiology: Theory And Practice by Kenrad E., M.D. Nelson, Carolyn F. Masters, Ph.D. Williams This comprehensive resource applies the fundamentals of epidemiology to the study of infectious diseases (ID). In the first section, readers will learn about basic epidemiologic methods for the study of ID plus be introduced to newer techniques like geographical information systems, mathematical modeling, and genetic laboratory tools. In the second section, the book covers major infectious... |
 | Infectious Diseases: A Clinical Short Course (LANGE Clinical Medicine) by Frederick Southwick Gain a full understanding of clinical infectious diseases in just thirty days . . No other resource makes clinical infectious diseases more manageable and easy to master than Infectious Diseases: A Clinical Short Course. This one-of-a-kind self-instruction tool is organized by system/region as opposed to pathogens -- simulating how common pathogens and disorders would be encountered in rounds... |
 | Infectious Diseases of the Dog and Cat , Revised Reprint (Infectious Diseases of the Dog and Cat) by Craig E. Greene Featuring full-color illustrations and hundreds of tables with diagnostic and therapeutic guidelines, this authoritative resource explores the diagnosis and treatment of canine and feline infectious diseases caused by viruses, rickettsiae, chlamydiae, mycoplasmas, bacteria, fungi, algae, protozoa, and unknown agents. Discussion of each disease includes diagnostic testing, indications and methods... |
 | Clinical Infectious Disease This clinically-oriented, user-friendly text is the best on the market for infectious disease. Complete and comprehensive, Schlossberg's text will be an effective reference for any practitioner who may encounter these afflictions. The orientation of the volume is multi-faceted: in addition to the traditional organization of organ system and pathogen-related information, this text includes... |
 | Infectious Diseases, Second Edition (EXPERT GUIDE SERIES- AMERICAN COLLEGE OF PHYSICIANS) Here s the expert guidance practitioners need to diagnose and treat the most commonly encountered infections! This fully revised and updated New Edition keeps readers current with the latest etiologic agents, the most appropriate diagnostic tests, and the most effective management options. The 2nd Edition features new chapters on Antimicrobial Agents for the Primary Care Physician and Prosthetic... |
 | The A to Z of Infectious Diseases (Concise Encyclopedia) by Carol Turkington, Bonnie Lee, M.d. Ashby In the past 25 years, more than 30 new germs affecting humans have emerged onto the medical scene, most of them rising from animals. New diseases like the avian flu, Ebola, SARS, and weaponized viruses such as anthrax and smallpox pose a growing danger to the world. With the threat of infectious diseases remaining constant, it is essential to have clear and concise information on this topic. "The... |
 | Modeling Infectious Diseases in Humans and Animals by Matt J. Keeling, Pejman Rohani For epidemiologists, evolutionary biologists, and health-care professionals, real-time and predictive modeling of infectious disease is of growing importance. This book provides a timely and comprehensive introduction to the modeling of infectious diseases in humans and animals, focusing on recent developments as well as more traditional approaches. Matt Keeling and Pejman Rohani move from... |
 | Infectious Disease Secrets by Robert H. Gates Infectious Disease Specialists, Colorado Springs, CO. Exam review offers information on most infectious diseases to help in diagnosis and treatment. In question/answer format, text provides bulleted lists and tables for quick review. Valuable pearls, tips, and memory aids are featured. For residents and medical students.... |
 | Managing Infectious Diseases in Child Care and Schools by American Academy of Pediatrics From the publisher of Red Book: Report of the Committee on Infectious Diseases, this new second edition of the award winning bestselling guide helps out-of-home caregivers prevent, identify, and respond to the most common childhood infectious diseases. Written in concise, nontechnical language and spiral-bound for easy use, the guide provides a valuable new tool to help caregivers handle child... |
 | Reese and Betts' A Practical Approach to Infectious Diseases (Practical Approach to Infectious Diseases (Betts)) by Robert F Betts, Stanley W Chapman, Robert L Penn Now in its thoroughly revised, updated Fifth Edition, this handbook is a practical, easily accessible, and authoritative guide to the diagnosis and treatment of infectious diseases. Leading experts present realistic clinical approaches to infectious disease problems seen in hospital and outpatient settings and offer up-to-the-minute advice on antimicrobial use--including specific recommendations... |
| © 2008 BrightSurf.com |